Sep.23 -- Johnson & Johnson has begun dosing up to 60,000 volunteers in a study of its Covid-19 vaccine, marking the first big U.S. trial of an inoculation that may work after just one shot. Bloomberg's Robert Langreth reports on "Bloomberg Markets."